Cargando…

A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte

Brain disorders are the leading cause of disability worldwide, affecting people’s quality of life and causing economic burdens. The current clinical diagnosis of brain disorders relies solely on individual phenotypes and lacks accurate molecular biomarkers. An emerging field of research centers arou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xueying, Yang, Huihui, Liu, Chunyu, Liu, Kefu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445044/
https://www.ncbi.nlm.nih.gov/pubmed/37621405
http://dx.doi.org/10.3389/fnmol.2023.1194210
_version_ 1785094088543961088
author Wang, Xueying
Yang, Huihui
Liu, Chunyu
Liu, Kefu
author_facet Wang, Xueying
Yang, Huihui
Liu, Chunyu
Liu, Kefu
author_sort Wang, Xueying
collection PubMed
description Brain disorders are the leading cause of disability worldwide, affecting people’s quality of life and causing economic burdens. The current clinical diagnosis of brain disorders relies solely on individual phenotypes and lacks accurate molecular biomarkers. An emerging field of research centers around extracellular vesicles (EVs), nanoscale membrane vesicles which can easily cross the blood–brain barrier. EVs in the blood are derived from various tissues, including the brain. Therefore, purifying central nervous system (CNS)-derived EVs from the blood and analyzing their contents may be a relatively non-invasive way to analyze brain molecular alterations and identify biomarkers in brain disorders. Recently, methods for capturing neuron-derived EVs (NDEs), astrocyte-derived EVs (ADEs), and oligodendrocyte-derived EVs (ODEs) in peripheral blood were reported. In this article, we provide an overview of the research history of EVs in the blood, specifically focusing on biomarker findings in six major brain disorders (Alzheimer’s disease, Parkinson’s disease, schizophrenia, bipolar disorder, depression, and autism spectrum disorder). Additionally, we discuss the methodology employed for testing CNS-derived EVs. Among brain disorders, Alzheimer’s disease has received the most extensive attention in EV research to date. Most studies focus on specific molecules, candidate proteins, or miRNAs. Notably, the most studied molecules implicated in the pathology of these diseases, such as Aβ, tau, and α-synuclein, exhibit good reproducibility. These findings suggest that CNS-derived EVs can serve as valuable tools for observing brain molecular changes minimally invasively. However, further analysis is necessary to understand the cargo composition of these EVs and improve isolation methods. Therefore, research efforts should prioritize the analysis of CNS-derived EVs’ origin and genome-wide biomarker discovery studies.
format Online
Article
Text
id pubmed-10445044
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-104450442023-08-24 A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte Wang, Xueying Yang, Huihui Liu, Chunyu Liu, Kefu Front Mol Neurosci Molecular Neuroscience Brain disorders are the leading cause of disability worldwide, affecting people’s quality of life and causing economic burdens. The current clinical diagnosis of brain disorders relies solely on individual phenotypes and lacks accurate molecular biomarkers. An emerging field of research centers around extracellular vesicles (EVs), nanoscale membrane vesicles which can easily cross the blood–brain barrier. EVs in the blood are derived from various tissues, including the brain. Therefore, purifying central nervous system (CNS)-derived EVs from the blood and analyzing their contents may be a relatively non-invasive way to analyze brain molecular alterations and identify biomarkers in brain disorders. Recently, methods for capturing neuron-derived EVs (NDEs), astrocyte-derived EVs (ADEs), and oligodendrocyte-derived EVs (ODEs) in peripheral blood were reported. In this article, we provide an overview of the research history of EVs in the blood, specifically focusing on biomarker findings in six major brain disorders (Alzheimer’s disease, Parkinson’s disease, schizophrenia, bipolar disorder, depression, and autism spectrum disorder). Additionally, we discuss the methodology employed for testing CNS-derived EVs. Among brain disorders, Alzheimer’s disease has received the most extensive attention in EV research to date. Most studies focus on specific molecules, candidate proteins, or miRNAs. Notably, the most studied molecules implicated in the pathology of these diseases, such as Aβ, tau, and α-synuclein, exhibit good reproducibility. These findings suggest that CNS-derived EVs can serve as valuable tools for observing brain molecular changes minimally invasively. However, further analysis is necessary to understand the cargo composition of these EVs and improve isolation methods. Therefore, research efforts should prioritize the analysis of CNS-derived EVs’ origin and genome-wide biomarker discovery studies. Frontiers Media S.A. 2023-08-09 /pmc/articles/PMC10445044/ /pubmed/37621405 http://dx.doi.org/10.3389/fnmol.2023.1194210 Text en Copyright © 2023 Wang, Yang, Liu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Neuroscience
Wang, Xueying
Yang, Huihui
Liu, Chunyu
Liu, Kefu
A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
title A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
title_full A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
title_fullStr A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
title_full_unstemmed A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
title_short A new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
title_sort new diagnostic tool for brain disorders: extracellular vesicles derived from neuron, astrocyte, and oligodendrocyte
topic Molecular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445044/
https://www.ncbi.nlm.nih.gov/pubmed/37621405
http://dx.doi.org/10.3389/fnmol.2023.1194210
work_keys_str_mv AT wangxueying anewdiagnostictoolforbraindisordersextracellularvesiclesderivedfromneuronastrocyteandoligodendrocyte
AT yanghuihui anewdiagnostictoolforbraindisordersextracellularvesiclesderivedfromneuronastrocyteandoligodendrocyte
AT liuchunyu anewdiagnostictoolforbraindisordersextracellularvesiclesderivedfromneuronastrocyteandoligodendrocyte
AT liukefu anewdiagnostictoolforbraindisordersextracellularvesiclesderivedfromneuronastrocyteandoligodendrocyte
AT wangxueying newdiagnostictoolforbraindisordersextracellularvesiclesderivedfromneuronastrocyteandoligodendrocyte
AT yanghuihui newdiagnostictoolforbraindisordersextracellularvesiclesderivedfromneuronastrocyteandoligodendrocyte
AT liuchunyu newdiagnostictoolforbraindisordersextracellularvesiclesderivedfromneuronastrocyteandoligodendrocyte
AT liukefu newdiagnostictoolforbraindisordersextracellularvesiclesderivedfromneuronastrocyteandoligodendrocyte